17-N-allylamino-17-demethoxygeldanamycin
Term · Oncology and biomedicine · MLC-T-ONC-000016
A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.
| Identifier | MLC-T-ONC-000016 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 17-AAG; tanespimycin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000016",
"term": "17-N-allylamino-17-demethoxygeldanamycin",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.",
"synonyms": [
"17-AAG",
"tanespimycin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/17-n-allylamino-17-demethoxygeldanamycin/"
}
Record 25 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.